同仁堂集团致歉

Core Viewpoint - Tongrentang Group has issued an apology regarding the recent controversy over "Antarctic krill oil," acknowledging the damage caused to consumer rights and committing to a zero-tolerance approach towards brand management [1] Group 1: Company Response - Tongrentang Group has initiated a special action for strict brand management, deploying a task force to Sichuan for a comprehensive investigation of the involved products [1] - The company has ordered the immediate removal of the implicated products from the market and is ensuring compliance with regulatory requirements for consumer compensation [1] - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading consumers [1] Group 2: Product Investigation - The Shanghai Consumer Protection Committee conducted tests on 15 popular Antarctic krill oil products, revealing that the "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" had a phospholipid content of 0, indicating potential fraud [3] - The implicated product was not directly produced by Beijing Tongrentang but was distributed by its subsidiary, Sichuan Health Pharmaceutical, with manufacturing outsourced to Habao Pharmaceutical [5] Group 3: Brand Management Issues - Habao Pharmaceutical admitted to not adding the claimed "Antarctic krill oil" during production, and the product packaging was created per the requirements of Sichuan Health Pharmaceutical [5] - The unauthorized use of the "Beijing Tongrentang" name on the product has led to legal proceedings initiated by the company against the involved parties [5] - There are concerns within the industry regarding Tongrentang's brand authorization management and quality control of its subsidiary products, which have contributed to a decline in consumer trust [6]